A detailed history of Highland Peak Capital, LLC transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Highland Peak Capital, LLC holds 200,000 shares of BHC stock, worth $1.44 Million. This represents 1.2% of its overall portfolio holdings.

Number of Shares
200,000
Previous 593,286 66.29%
Holding current value
$1.44 Million
Previous $4.76 Billion 55.4%
% of portfolio
1.2%
Previous 3.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 09, 2024

BUY
$6.53 - $8.23 $3.87 Million - $4.88 Million
593,286 New
593,286 $4.76 Billion
Q2 2023

Aug 04, 2023

BUY
$5.72 - $8.8 $2.71 Million - $4.16 Million
472,944 Added 89.28%
1,002,674 $8.02 Billion
Q1 2023

May 09, 2023

SELL
$6.28 - $9.85 $496,289 - $778,415
-79,027 Reduced 12.98%
529,730 $4.29 Billion
Q4 2022

Feb 06, 2023

BUY
$6.09 - $7.93 $3.71 Million - $4.83 Million
608,757 New
608,757 $3.82 Billion

Others Institutions Holding BHC

About Bausch Health Companies Inc.


  • Ticker BHC
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 361,728,000
  • Market Cap $2.6B
  • Description
  • Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...
More about BHC
Track This Portfolio

Track Highland Peak Capital, LLC Portfolio

Follow Highland Peak Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Highland Peak Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Highland Peak Capital, LLC with notifications on news.